Our CDMO leverages Pfizer’s cutting-edge development and commercial manufacturing solutions to offer contract development & manufacturing services from small to large scale for oral solids, sterile injectables, small molecules and biologics; as well as regulatory services.
Pfizer CentreOne harnesses Pfizer’s manufacturing network, expertise and capabilities across the spectrum of drug substance, drug products and pharmaceutical delivery methods.
Experts in oral solid dosage, Pfizer CentreOne draws on its global network to support our partners in developing and manufacturing tablets, capsules, pellets and other solid dosage forms using advance manufacturing capabilities in semi-solids, wet/dry granulation, blending, coating, extrusion, compression, printing, high containment and hormone manufacture.
Around the world, our Pfizer scientific and manufacturing experts leverage their decades of experience supporting a broad range of complex therapeutics - alongside our specialized facilities to unlock the potential of your SI drug substance (liquid or lyophilized) and product (PFS, vials, cartridges).
Our sterile injectables platform includes deep knowledge and experience helping partners with:
Pfizer CentreOne’s biologics production capabilities include:
Pfizer CentreOne supports our partners in custom small molecule API manufacturing, with significant experience in:
A steady supply of critical ingredients for over 50 years. Off the shelf pharma APIs and intermediates available in reliable supply in both clinical and commercial quantities:
Pfizer CentreOne’s cell and gene therapy platform helps partners develop and manufacture scalable viral vectors across multiple serotypes, in with a significant number of GMP batches with and proven quality control.
Pfizer CentreOne’s pharmaceutical development services cover the entire pharmaceutical development lifecycle, including:
We offer lifecycle support to our partners, drawing upon the scientific mastery of Pfizer CentreOne’s team of creative scientists and problem-solvers.
Drawing on decades of experience and our global network of regulatory specialists, Pfizer CentreOne helps plan and execute complex pharmaceutical tech transfer projects at scale.
Pfizer CentreOne provides pharmaceutical contract regulatory services including support and guidance across our portfolio of modalities. We have regulatory intelligence for more than 150 countries, to support you with many regulatory requirements around the globe.
We offer our partners our expertise and experience in:
For decades, Pfizer CentreOne has been listening, solving, and guiding its partners’ drug projects on the journey to patients. By taking an open and collaborative approach to drug development and manufacturing, our CDMO assures full transparency by continually striving to deliver on our promises.
Explore our CDMO Details